Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal

NACompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
ObesityPhentermine Withdrawal
Interventions
DRUG

Abrupt cessation of phentermine pharmacotherapy

Patients will be asked to cease taking phentermine, then to complete psychometric scales 24 and 48 hours later. Patients will be examined at 48 hours by physician who will determine if phentermine should be continued or discontinued.

Trial Locations (2)

95661

Center for Weight Management, Roseville

95816

Center for Weight Management, Sacramento

All Listed Sponsors
collaborator

American Society of Bariatric Physicians

OTHER

lead

Center for Weight Management, California

OTHER

NCT01402674 - Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal | Biotech Hunter | Biotech Hunter